Avocats – United States

David Simon

Partner, Co-Head

Skadden, Arps, Slate, Meagher & Flom LLP

David Simons

Partner

Boies Schiller Flexner LLP

David Singh

Co-Head of Weil’s national Complex Commercial Litigation practice

Weil, Gotshal & Manges LLP

David Slotkin

David Slotkin is a partner in Proskauer’s Corporate Department and a member of the Mergers & Acquisitions and Real Asset Groups. David’s practice specializes in public and private transactions, including mergers, acquisitions, sales, divestitures, tender offers, joint ventures, spinoffs, debt and equity securities offerings, restructurings and corporate governance. He has extensive experience advising clients on complex transactions across all real assets classes, including digital infrastructure and hospitality. He works with both U.S. and international clients, ranging from newly formed public companies to established global brands, both benefiting from his deep expertise in complex transactions, strategic decision making, governance and compliance. In addition to his transactional practice, David provides strategic counsel to management teams, boards of directors, audit committees and special committees on corporate governance matters. He advises public companies on all aspects of regulatory compliance, including federal securities laws and securities exchange listing requirements.

Proskauer Rose LLP

David Solander

Partner

DLA Piper LLP (US)

David Stein

Partner

Withers

David Sterling

Partner

Baker Botts L.L.P.

David Stier

DLA Piper LLP (US)

David Strickland

Partner

White & Case LLP

David Sturgeon

Dave B. Sturgeon | Morrison Foerster David Sturgeon is a partner in Morrison Foerster’s Federal Tax practice. Dave advises clients on a broad range of complex business transactions, including domestic and cross-border mergers and acquisitions, joint ventures, spin-offs and other divestitures, as well as financings, refinancings, restructurings and other business transactions.

Morrison Foerster

David Suozzi

Partner

Shartsis Friese LLP

David Super

David Super offers first-chair trial experience to clients across multiple industries. He handles complex commercial litigation in federal and state courts throughout the country. David’s experience includes litigation involving regulatory and environmental challenges to major infrastructure projects, and environmental claims under the Clean Air Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response (RCRA), Compensation, and Liability Act (CERCLA), commonly known as Superfund. Beyond his experience in environmental litigation, David has taken a lead role in a diverse set of complex commercial disputes, including defense of class actions, allegations of fraud and other business torts, breach of contract, partnership disputes, actions before federal agencies, energy issues and constitutional takings.

Bracewell LLP

David Sweeney

Clifford Chance

David Szeker

Real Estate and Hospitality Transactions

Kasowitz LLP

David T. Della Rocca

David Della Rocca, former Vice Chair of the Global Tax Department and former Chair of the Global Executive Compensation, Employment & Benefits Practice, advises public and private companies on complex executive compensation and employee benefits matters. David leverages deep experience and his role as a trusted advisor to help clients navigate: Executive compensation and employee benefit matters in connection with mergers and acquisitions, spinoffs, and initial public offerings Equity-based and other incentive compensation plans and arrangements, including stock option plans, employee stock purchase plans, and deferred compensation plans Day-to-day executive compensation and employee benefit issues that arise in public and private companies

Latham & Watkins

David Tarr

Click here for attorney bio.

Paul, Weiss, Rifkind, Wharton & Garrison LLP

David Taub

Tax Partner

Latham & Watkins

David Tegeler

David Tegeler is a partner in Proskauer's Corporate Department and the Private Funds Group, and also head of the Boston office. He previously served as global co-head of the Private Funds Group for many years. David concentrates his practice on representing asset managers in a broad range of matters, including private investment fund formation; governance, succession planning and other “upper tier” concerns; regulatory advice; and asset manager M&A. In addition, David has significant experience in buy and sell side secondary transactions, fund restructurings, direct secondary transactions and private investment fund finance. He also represents U.S. and non-U.S. institutional investors in their investments in all types of private investment funds. David has over 30 years of experience in the private equity industry. He has represented numerous domestic and international private investment firms in their fund formation and operations, including buyout, growth equity, credit, venture capital, natural resource, special situation, secondary, and funds of funds, as well as geographic and sector specific funds.

Proskauer Rose LLP

David Teh

David Teh leads the Alternative Capital and Private Credit team and has deep and versatile experience advising direct lenders, investment banks and corporate borrowers across many sectors on a broad range of direct loans and syndicated credit facilities. His work includes both U.S. and cross-border leveraged acquisition financings, unitranche facilities, ‘recurring revenue’ loans, ‘stretch senior’ loans, first and second lien credit facilities and leveraged and investment grade corporate credit facilities. David also advises on financings for insurance solutions, hybrid capital, backleverage and other capital solutions for special situations, recapitalizations and real asset financings.

Simpson Thacher & Bartlett LLP

David Teigman

David Teigman is a partner in Proskauer's Tax Department and a member of the Employee Benefits & Executive Compensation Group. David focuses his practice on executive compensation and benefit matters, principally in connection with mergers and acquisitions, securities offerings and senior executive employment relationships. David regularly counsels public and private companies on compensatory and benefit arrangements, such as equity-based incentives, cash-based incentives and employment, change-in-control, retention, separation and consulting agreements. He also advises on corporate governance, tax law and securities law related to employment matters. A frequent author, David has published the following articles: “Share Reserve and Other Limits in Public Company Equity Plans” (Practical Law) “Roadmap to Providing Appropriate Incentives to Employees When Your Company is Going to be Sold” (The M&A Lawyer) “Taxation of an Option Exercise When the Shares are Subject to a Substantial Risk of Forfeiture” (Practical Law) David received his J.D., cum laude, from the University of Buffalo, where he was the Editor-in-Chief of the Buffalo Law Review and the Executive Editor of the Public Interest Law Journal, and his B.S. from Cornell University.

Proskauer Rose LLP

David Tetrick

Partner / Chief Human Resources Officer

King & Spalding

David Thatch

Partner

White & Case LLP

David Thomas

Dave Thomas has an insurance recovery and complex commercial litigation practice. Dave represents and counsels policyholders in litigation and non-litigation matters relating to a diverse array of commercial insurance lines, including cybersecurity and privacy, commercial general liability, umbrella, D&O, financial institution bonds, bankers professional liability, employment practices liability, and first-party property and business interruption. His litigation experience includes both traditional insurance coverage and recovery of funds under insurance-related collateralization programs. Dave also advises corporate policyholders in applying for or reviewing various coverages. In addition, Dave represents and counsels individual property owners in high-value insurance claims, including due to wildfires, mudslides, and other natural disasters. Dave’s practice extends to a wide variety of corporate and commercial litigation involving contract disputes, tort claims, unfair competition and trade practices claims, and corporate disputes. He also has represented individual claimants harmed by fraudulent and unfair practices in the sale of life and health insurance products and insurance-related transactions.

Blank Rome LLP

David Tolley

David Tolley, Chair of the Boston Litigation & Trial Department, represents healthcare and life sciences companies in high-stakes government investigations and litigation. David represents clients in a variety of investigative, litigation, regulatory, and compliance matters. He represents a full spectrum of industry clients, including: Hospital systems Insurers Medical device and pharmaceutical companies Pharmacy benefit managers Pharmaceutical distributors He helps clients navigate their highest-stakes issues involving the False Claims Act, the Anti-Kickback Statute, and their state analogs. He draws on extensive experience with government regulators and prosecutors including those from the: Department of Justice Department of Health and Human Services (HHS) - Office of Inspector General Centers for Medicare & Medicaid Services HHS - Office for Civil Rights State Attorneys General David helps clients frame complex issues and advocates on their behalf based on a sophisticated understanding of both the law and the industry, his background in medical ethics and health policy, and his ability to deescalate and navigate strategically through high-pressure situations. Industry Leadership and Pro Bono David serves as an advisory board member of The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. He has served as a Chapter President for the Healthcare Financial Management Association and is a member of the American Health Lawyers Association. He works regularly with the Center for Health Law Policy Innovation at Harvard Law School, pursuing pro bono litigation against state Medicaid agencies on behalf of people with Hepatitis C denied access to curative therapies.

Latham & Watkins